No Prescription |
 |
 | ||
|
Timolol Generic Betimol |
|
| ||
No Prescription » Prescription Drugs 16 » Timolol Generic Betimol Timolol is used to treat glaucoma a condition in which increased pressure in the eye can lead to gradual loss of vision. Timolol decreases the pressure in the eye.Timolol comes as eyedrops and eye gel. Timolol eyedrops usually are applied once or twice a day at evenly spaced intervals until pressure in your eyeball is controlled (about 4 weeks). Then you may be able to use it once a day. Timolol gel usually is applied once a day. Follow the directions on your prescription label carefully and ask doctor or pharmacist to explain any part you do not understand. Use timolol exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.Timolol controls glaucoma but does not cure it. Continue to use timolol even if you feel well. Do not stop using timolol without talking to your doctor. Buy Timolol Generic Betimol and other Prescription Drugs 16 products online at Medstore. Buy Online at Medstore - Click Here!
About Timolol Generic Betimol: Product Type: Prescription Drugs 16 Timolol ( Generic Betimol Timoptic Timoptic-XE ) Timolol (Generic Betimol Timoptic Timoptic-XE) Generic Betimol Timoptic Timoptic-XE 0.25% Generic Betimol Timoptic Timoptic-XE Timolol
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
